drugset / Trial / NCT02812719

Treatment of Melasma With Glycolic Acid-Salicylic Acid Peel Versus Glycolic Acid Peel

NCT02812719

Phase 0 Withdrawn Boston Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this pilot study is to conduct a controlled comparison of the efficacy and safety of a combination peel (glycolic acid and salicylic acid) as compared to glycolic acid peel alone in the treatment of melasma. Our primary outcome is objective improvement in pigmentation as evaluated using a colorimeter. Our secondary outcomes are subjective improvement using the Melasma Area and Severity Index (MASI) and Patient and Physician Global assessment, as well as assessment of treatment tolerability and patient satisfaction.

Timeline

Start
2018-07
Primary completion
2018-12
Completion
2019-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glycolic acid Small molecule 35 % Topical
Subject salicylic acid Small molecule 20 % Topical